UBS Group’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-50,844
Closed -$7K 8535
2019
Q2
$7K Buy
50,844
+38,640
+317% +$7.52K ﹤0.01% 7292
2019
Q1
$4K Sell
12,204
-6,717
-36% -$2.78K ﹤0.01% 7306
2018
Q4
$8K Buy
18,921
+15,505
+454% +$9.13K ﹤0.01% 7386
2018
Q3
$3K Sell
3,416
-2,568
-43% -$2.52K ﹤0.01% 7702
2018
Q2
$7K Buy
5,984
+968
+19% +$1.34K ﹤0.01% 7374
2018
Q1
$8K Hold
5,016
﹤0.01% 7039
2017
Q4
$7K Sell
5,016
-21,364
-81% -$29.5K ﹤0.01% 7264
2017
Q3
$39K Buy
26,380
+1,812
+7% +$2.87K ﹤0.01% 5983
2017
Q2
$47K Sell
24,568
-6,032
-20% -$9.13K ﹤0.01% 5697
2017
Q1
$52K Sell
30,600
-13,702
-31% -$28.5K ﹤0.01% 5505
2016
Q4
$93K Sell
44,302
-15,194
-26% -$41.4K ﹤0.01% 5349
2016
Q3
$199K Buy
59,496
+18,496
+45% +$55.6K ﹤0.01% 4553
2016
Q2
$91K Sell
41,000
-5,044
-11% -$16.4K ﹤0.01% 5098
2016
Q1
$144K Buy
46,044
+1,785
+4% +$4.62K ﹤0.01% 4718
2015
Q4
$125K Buy
44,259
+259
+0.6% +$828 ﹤0.01% 5042
2015
Q3
$230K Buy
+44,000
New +$253K ﹤0.01% 4521

Other funds holding HLTH

UBS Group's HLTH Position: Q3 2019 in Review

UBS Group sold out of Nobilis Health Corp. (HLTH) in Q3 2019, closing a stake of 50,844 shares — an estimated $7K sold.

UBS Group first reported a position in HLTH in Q3 2015 and held it in 16 quarters. The position peaked at $230K in Q3 2015. 3 funds tracked by Wall St. Rank hold HLTH as of Q3 2019.

  • UBS Group reported no remaining Nobilis Health Corp. position as of Q3 2019 after selling out during the quarter.
  • UBS Group sold 50,844 Nobilis Health Corp. shares in Q3 2019, an estimated $7K.
  • UBS Group first reported a position in Nobilis Health Corp. in Q3 2015 and held it in 16 quarters.
  • UBS Group's Nobilis Health Corp. position peaked at $230K in Q3 2015.
  • 3 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q3 2019.

Based on UBS Group's 13F filing for Q3 2019, filed 14 Nov 2019.